Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments.

Gordon Graham1, Leon Aarons

  • 1Novartis Pharma AG, Lichtstrasse 35, Basel, Switzerland. gordon.graham@novartis.com

Statistics in Medicine
|February 8, 2006
PubMed
Summary

This study introduces a flexible pharmacokinetic sampling window approach for clinical trials. This method allows blood collection at convenient times, ensuring informative data for drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

AI-driven reclassification of multiple sclerosis progression.

Nature medicine·2025
Same author

Publisher Correction: Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data.

The AAPS journal·2025
Same author

Simultaneous Estimation of fm and F<sub>G</sub> Values Directly from Clinical Drug-Drug Interaction Study Data.

The AAPS journal·2025
Same author

Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.

Multiple sclerosis (Houndmills, Basingstoke, England)·2024
Same author

Hierarchical cluster analysis and nonlinear mixed-effects modelling for candidate biomarker detection in preclinical models of cancer.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2024

Area of Science:

  • Pharmacokinetics
  • Clinical Trial Design
  • Drug Development

Background:

  • Traditional pharmacokinetic studies require fixed blood sampling times, challenging in outpatient settings.
  • Convenient sampling in late-phase trials can yield uninformative data.
  • Current methods struggle with flexibility in real-world clinical trial data collection.

Purpose of the Study:

  • To propose a flexible pharmacokinetic study design.
  • To enable blood sample collection within defined time windows.
  • To ensure satisfactory parameter estimation despite flexible sampling.

Main Methods:

  • Developed a sampling window approach based on D-optimum pharmacokinetic sampling times.
  • Defined time intervals around optimal sampling points.

Related Experiment Videos

  • Ensured specified efficiency compared to fixed-time D-optimum designs.

    • Main Results:

    • The proposed sampling window approach allows for greater flexibility in blood collection timing.
    • Data collected using this method can still yield satisfactory pharmacokinetic parameter estimation.
    • The design maintains a specified level of efficiency compared to traditional fixed-time designs.

    Conclusions:

    • The sampling window approach offers a practical solution for pharmacokinetic data collection in flexible clinical trial settings.
    • This method enhances the feasibility of pharmacokinetic studies in late-phase drug development.
    • It balances the need for convenient sampling with the requirement for robust pharmacokinetic analysis.